ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 63 filers reported holding ONCOMED PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $347,000 | -82.5% | 20,900 | -75.9% | 0.00% | -75.0% |
| Q2 2015 | $1,978,000 | -19.7% | 86,600 | -15.7% | 0.01% | -20.0% |
| Q1 2015 | $2,463,000 | +17.1% | 102,700 | +6.2% | 0.01% | +11.1% |
| Q4 2014 | $2,104,000 | +15.0% | 96,700 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $1,830,000 | -16.2% | 96,700 | +3.2% | 0.01% | -10.0% |
| Q2 2014 | $2,183,000 | -20.1% | 93,700 | +15.4% | 0.01% | -28.6% |
| Q1 2014 | $2,732,000 | +12.7% | 81,200 | -1.1% | 0.01% | +16.7% |
| Q4 2013 | $2,424,000 | +136.7% | 82,100 | +22.7% | 0.01% | +100.0% |
| Q3 2013 | $1,024,000 | – | 66,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,108,815 | $4,273,000 | 0.48% |
| Birchview Capital, LP | 372,557 | $387,000 | 0.24% |
| Perceptive Advisors | 1,719,111 | $1,787,000 | 0.05% |
| Fondren Management LP | 25,136 | $26,000 | 0.02% |
| Cannell & Co. | 281,983 | $293,000 | 0.01% |
| APPLETON PARTNERS INC/MA | 66,206 | $69,000 | 0.01% |
| Quinn Opportunity Partners LLC | 66,162 | $69,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 38,000 | $40,000 | 0.01% |
| Candriam S.C.A. | 380,000 | $395,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 5,451,400 | $5,669,000 | 0.00% |